Source: PIB Contents1 What is the News?2 About BBV154:3 About Mission COVID Suraksha 4 About BIRAC What is the News? BBV154, the first Nasal Vaccine against Covid-19 has received the regulator’s nod for conducting Phase 2 and 3 clinical trials. About BBV154: BBV154 is an intranasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine. It is the first… Continue reading First Nasal Vaccine Developed by Bharat Biotech supported by DBT-BIRAC gets nod of regulator for Phase 2 Trial
Tag: nasal vaccine
Search Articles
Latest Articles
- UPSC Prelims Marathon 27th April – Awareness in Field of IT & Space – II – 2024
- [Answered] UPSC Mains Answer writing 26 April, 2024 I Mains Marathon
- 10 PM UPSC Current Affairs Quiz 26 April, 2024
- 9 PM UPSC Current Affairs Articles 26 April, 2024
- Changes in India’s job market before and after the COVID-19 pandemic
- Claims that solar and wind energy are the cheapest forms of electricity are misleading
- Supreme Court’s view on false advertisement
- The issue of Winning an Election with Contest
- A week food chain
- Health on a hot planet